We’ve just launched a new portal to help you explore stocks, crypto, ETFs, and more data

VX1

391.79999 EUR
5.35
1.38%
Last update May 16, 9:33 PM CEST
Market closed
Day range
385.95001
391.79999
Previous close
386.45001
Open
385.95001
Access this stock data via API
Subscribe
Vertex Pharmaceuticals Inc.
391.80
5.35
1.38%

Financials

Income statement

Fiscal date Mar 2025 Dec 2024 Sep 2024 Jun 2024
Total reported revenue 2.8B 2.9B 2.8B 2.6B
Cost of revenue 363M 423.4M 392.6M 371.9M
Gross profit 2.4B 2.5B 2.4B 2.3B
Operating expense
Research & development 979.7M 998.7M 875.9M 966.6M
Selling general and admin 396.4M 377.6M 371.8M 372.2M
Other operating expenses
Operating income 1.0B 1.1B 1.1B 934.9M
Non operating interest income
Income 120.9M 128.2M 132.2M 156.5M
Expense 3M 2.8M 7.5M 9.9M
Other income expense -418.6M -101.2M -32.2M -4.5B
Pretax income 730.4M 1.1B 1.2B -3.4B
Tax provision 84.1M 223.5M 178.7M 202.4M
Net income 646.3M 913M 1.0B -3.6B
Basic EPS 2.5 3.6 4.1 -13.9
Diluted EPS 2.5 3.5 4.0 -13.9
Basic average shares 287.8M 288.5M 289.0M 289.2M
Diluted average shares 290.7M 291.8M 292.4M 289.2M
EBITDA 1.2B 1.3B 1.3B 1.1B
Net income from continuing op. 646.3M 913M 1.0B -3.6B
Minority interests
Preferred stock dividends
Market closed

Exchange is currently closed (non-working day)
Main market opens in 17 hours 50 minutes

14:09
00:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CEST, UTC+02:00).